Dexco (BSP:DXCO3) Research & Development: R$0 Mil (TTM As of Mar. 2026)


BSP:DXCO3 Dexco SA BSP:DXCO3
84 GF Score
Price R$4.96
GF Value R$7.20
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Dexco Research & Development?

Dexco BSP:DXCO3 +0.81% 84 Research & Development is R$0 Mil as of Mar. 2026. GuruFocus rates BSP:DXCO3 with a GF Score™ of 84/100 and a GF Value™ of R$7.20 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dexco's Research & Development for the three months ended in Mar. 2026 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was R$0 Mil.

Dexco  (BSP:DXCO3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dexco Research & Development Related Terms

Dexco Research & Development Historical Data

* Premium members only.

The historical data trend for Dexco's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dexco Research & Development Chart

Dexco Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dexco Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BSP:DXCO3
84GF Score
Dexco SA BSP:DXCO3
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dexco Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R$0 Mil mean?
Dexco (BSP:DXCO3) has a Research & Development of R$0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dexco and its competitors.
Is Dexco's Research & Development too high?
Dexco's current Research & Development is R$0 Mil. Overall, Dexco has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dexco's Research & Development compare to SSD and UFPI?
Dexco's Research & Development of R$0 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Forest Products company?
A good Research & Development depends on the Forest Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dexco and its competitors. Dexco's current Research & Development is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dexco stock overvalued right now?
Based on GuruFocus' analysis, Dexco (BSP:DXCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$7.20, compared to a current price of R$4.96 — trading 31.1% below its estimated fair value. The current Research & Development is R$0 Mil. Dexco's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dexco (BSP:DXCO3), the current Research & Development is R$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dexco (BSP:DXCO3) Overvalued in 2026?

Based on GuruFocus' analysis, Dexco stock appears to be undervalued. The current stock price of R$4.96 is trading 31.1% below its estimated GF Value™ of R$7.20. GuruFocus considers Dexco to be Possible Value Trap.

Key valuation signals for BSP:DXCO3:

  • Research & Development: R$0 Mil
  • GF Value™: R$7.20 vs. price of R$4.96 (31.1% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the BSP:DXCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dexco Business Description

Address Paulista Avenue, 1938, 5th floor, Sao Paulo, SP, BRA, 01310-942
Dexco SA is engaged in the production of wooden panels, vitreous chinaware, metal bathroom fittings and showers, and ceramic and cement floors. Its segments are: The Wood segment operates four industrial units in Brazil and three in Colombia producing MDP panels (medium density panels), MDF and HDF panels (medium and high fiber density panels), under the Duratex brand, the Durafloor brand for laminates and semi-finished components for furniture; The Deca segment operates in Brazil, producing vitreous chinaware, metal fittings, and showers, under the brands Deca, Hydra, Belize and Elizabeth; the Ceramic Tile segment operates four industrial plants in Brazil, producing ceramic tiles, under the Ceusa, Portinari, and Castelatto brands; and Soluble Cellulose Segment.
84GF Score

Get the complete analysis for BSP:DXCO3

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.96
Price
R$7.20
GF Value